Preferential location of circulating activated cyclophosphamide within the erythrocyte
- 1 March 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 65 (5) , 711-712
- https://doi.org/10.1002/1097-0215(19960301)65:5<711::aid-ijc2910650503>3.0.co;2-h
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Measurement of 4-hydroxycyclophosphamide in serum by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Description of an instrument for separation of red cells from plasma and measurement of red cell volumeClinical Biochemistry, 1994
- The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometryJournal of Mass Spectrometry, 1994
- Chromatographic analysis of anticancer drugsJournal of Chromatography B: Biomedical Sciences and Applications, 1990